OncoMatch/Clinical Trials/NCT07635147
Decision Support Tool for Patients With Advanced Breast Cancer
Is NCT07635147 recruiting? Yes, currently enrolling (Jul 2026). This NA trial studies non-drug interventions for breast cancer metastatic.
The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and their providers regarding their care and treatment. As part of this study, the researchers will evaluate a decision support tool called COAST that was designed to support patients and providers in having meaningful conversations. The main questions it aims to answer are: 1. Can the COAST tool improve the quality of communication between patients and their oncology providers? 2. Is the COAST tool acceptable, appropriate, and easy to use at NYP-Weill Cornell Medicine, NYP-Brooklyn Methodist Hospital and NYP-Queens? Participants will be asked to fill out two surveys: one before they use the COAST tool and another about 2 - 4 weeks later. Some patients will also be invited for an interview.
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Disease stage
Required: Stage IV
Metastatic disease required
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- NewYork-Presbyterian Brooklyn Methodist Hospital · Brooklyn, New York
- NewYork-Presbyterian David H. Koch Center · New York, New York
- NewYork-Presbyterian Medical Group Queens · New York, New York
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07635147 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage IV is required (metastatic disease required).
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages